"It's easy to deliver and doesn't need any syringe or needle and most important it produces three immune responses, IgG, IgA, & T cell response. No other vaccine in the world can produce three responses," said Dr Krishna Ella, Chairman & MD, Bharat Biotech on the launch of the 'iNCOV
Mandaviya unveiled the Inncovacc- the first India-made nasal Covid-19 vaccine today in the presence of Union Minister of State (IC) for Science and Technology, Jitendra Singh.
As the country's marked its 74th Republic Day, Union Health Minister Dr Mansukh Mandaviya and Union Science and Technology Minister Jitendra Singh launched Bharat Biotech's first India-made nasal Covid-19 vaccine, iNCOVACC, on Thursday.
According to a new study, a simple nasal spray significantly reduced snoring and breathing difficulties in children and halved the number needing to have their tonsils removed.
A simple nasal spray significantly reduced snoring and breathing difficulties in children and halved the number needing to have their tonsils removed, according to a new study.
As the Covid-19 pandemic showed, potentially dangerous new viruses can begin to spread in the population well before the global public health surveillance system can detect them.
Bharat Biotech's nasal vaccine - iNCOVACC has been approved by the Government of India and will be used as a heterologous booster dose for those above 18 years of age
A medication in development for obstructive sleep apnoea (OSA) showed promising results after being tested in humans for the first time by Flinders University researchers.
The Central Drugs Standard Control Organization (CDSCO) has approved India's first intra-nasal vaccine for COVID for restricted use in emergency situations in people aged 18 and up.